Short Communication: HIV-1 Variants That Use Mouse CCR5 Reveal Critical Interactions of gp120's V3 Crown with CCR5 Extracellular Loop 1

被引:1
|
作者
Platt, Emily J. [1 ]
Durnin, James P. [1 ]
Kabat, David [1 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; CHEMOKINE RECEPTOR CCR5; ENVELOPE GLYCOPROTEIN; ADAPTIVE MUTATIONS; AMINO-TERMINUS; N-TERMINUS; CORECEPTOR; ENTRY; BINDING; FUSION;
D O I
10.1089/aid.2015.0131
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The CCR5 coreceptor amino terminus and extracellular (ECL) loops 1 and 2 have been implicated in HIV-1 infections, with species differences in these regions inhibiting zoonoses. Interactions of gp120 with CD4 and CCR5 reduce constraints on metastable envelope subunit gp41, enabling gp41 conformational changes needed for infection. We previously selected HIV-1(JRCSF) variants that efficiently use CCR5(Delta 18) with a deleted amino terminus or CCR5(HHMH) with ECL2 from an NIH/Swiss mouse. Unexpectedly, the adaptive gp120 mutations were nearly identical, suggesting that they function by weakening gp120's grip on gp41 and/or by increasing interactions with ECL1. To analyze this and further wean HIV-1 from human CCR5, we selected variants using CCR5(HMMH) with murine ECL1 and 2 sequences. HIV-1(JRCSF) mutations adaptive for CCR5(Delta 18) and CCR5(HHMH) were generally maladaptive for CCR5(HMMH), whereas the converse was true for CCR5(HMMH) adaptations. The HIV-1(JRCSF) variant adapted to CCR5(HMMH) also weakly used intact NIH/Swiss mouse CCR5. Our results strongly suggest that HIV-1(JRCSF) makes functionally critical contacts with human ECL1 and that adaptation to murine ECL1 requires multiple mutations in the crown of gp120's V3 loop.
引用
收藏
页码:992 / 998
页数:7
相关论文
共 50 条
  • [21] Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120
    Choe, H
    Li, WH
    Wright, PL
    Vasilieva, N
    Venturi, M
    Huang, CC
    Grundner, C
    Dorfman, T
    Zwick, MB
    Wang, LP
    Rosenberg, ES
    Kwong, PD
    Burton, DR
    Robinson, JE
    Sodroski, JG
    Farzan, M
    CELL, 2003, 114 (02) : 161 - 170
  • [22] V3 determinants of HIV-1 escape from the CCR5 inhibitors Maraviroc and Vicriviroc
    Berro, Reem
    Klasse, Per Johan
    Moore, John P.
    Sanders, Rogier W.
    VIROLOGY, 2012, 427 (02) : 158 - 165
  • [23] HIV-1 adaptation to low levels of CCR5 results in V3 and V2 loop changes that increase envelope pathogenicity, CCR5 affinity and decrease susceptibility to Maraviroc
    Garg, Himanshu
    Lee, Raphael T. C.
    Maurer-Stroh, Sebastian
    Joshi, Anjali
    VIROLOGY, 2016, 493 : 86 - 99
  • [24] Clinical resistance to vicriviroc through adaptive V3 loop mutations in HIV-1 subtype D gp120 that alter interactions with the N-terminus and ECL2 of CCR5
    Ogert, Robert A.
    Hou, Yan
    Ba, Lei
    Wojcik, Lisa
    Qiu, Ping
    Murgolo, Nicholas
    Duca, Jose
    Dunkle, Lisa M.
    Ralston, Robert
    Howe, John A.
    VIROLOGY, 2010, 400 (01) : 145 - 155
  • [25] Role of V3 independent domains on a dualtropic human immunodeficiency virus type 1 (HIV-1) envelope gp120 in CCR5 coreceptor utilization and viral infectivity
    Foda, M
    Harada, S
    Maeda, Y
    MICROBIOLOGY AND IMMUNOLOGY, 2001, 45 (07) : 521 - 530
  • [26] SIGNATURE MUTATIONS IN V3 AND BRIDGING SHEET DOMAIN OF HIV-1 GP120 HIV-1 ARE SPECIFICALLY ASSOCIATED WITH DUAL TROPISM AND MODULATE THE INTERACTION WITH CCR5 N-TERMINUS
    Alteri, C.
    Artese, A.
    Zhang, J. M.
    Mercurio, F.
    Costa, G.
    Stazi, F.
    Fabeni, L.
    Bertoli, A.
    Forbici, F.
    Salpini, R.
    Dimonte, S.
    Alcaro, S.
    Ceccherini-Silberstein, F.
    Perno, C. F.
    Svicher, V.
    INFECTION, 2011, 39 : S39 - S39
  • [27] Differential Use of CCR5 by HIV-1 Clinical Isolates Resistant to Small-Molecule CCR5 Antagonists
    Henrich, Timothy J.
    Lewine, Nicolas R. P.
    Lee, Sun-Hee
    Rao, Suhas S. P.
    Berro, Reem
    Gulick, Roy M.
    Moore, John P.
    Tsibris, Athe M. N.
    Kuritzkes, Daniel R.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (04) : 1931 - 1935
  • [28] Binding Thermodynamics of the N-Terminal Peptide of the CCR5 Coreceptor to HIV-1 Envelope Glycoprotein gp120
    Brower, Evan T.
    Schon, Arne
    Klein, Jeffrey C.
    Freire, Ernesto
    BIOCHEMISTRY, 2009, 48 (04) : 779 - 785
  • [29] Modeling of CCR5 Recognition by HIV-1 gp120: How the Viral Protein Exploits the Conformational Plasticity of the Coreceptor
    Jacquemard, Celien
    Koensgen, Florian
    Colin, Philippe
    Lagane, Bernard
    Kellenberger, Esther
    VIRUSES-BASEL, 2021, 13 (07):
  • [30] Preferential recognition of monomeric CCR5 expressed in cultured cells by the HIV-1 envelope glycoprotein gp120 for the entry of R5 HIV-1
    Nakano, Yusuke
    Monde, Kazuaki
    Terasawa, Hiromi
    Yuan, Yuzhe
    Yusa, Keisuke
    Harada, Shinji
    Maeda, Yosuke
    VIROLOGY, 2014, 452 : 117 - 124